Apple initiates a U.S. research program that lets participants ask healthārelated questions to an AI powered by clinical literature.
According to TechCrunch, Apple has partnered with the healthcareāfocused artificialāintelligence firm OpenEvidence to roll out a new study app that will run on iPhoneāÆ15 or later devices equipped with iOSāÆ26 and Apple Intelligence. The initiative, announced on 15āÆNovemberāÆ2026, invites U.S. residents aged 21āÆor older to take part in a longitudinal study that could involve as many as 200āÆ000 participants over a period exceeding 12āÆmonths.
Study design and eligibility
Based on reports, enrollment is limited to users who meet three technical criteria: an iPhoneāÆ15 (or newer), iOSāÆ26 (or newer), and the Apple Intelligence feature turned on. Participants must also reside in the United States and be at least 21āÆyears old. The app became available for download āstarting todayā for eligible U.S. users, according to TechCrunch.
How the app works
According to TechCrunch, the study app allows users to type healthārelated questions in a chatālike interface, much like they would with existing largeālanguageāmodel chatbots such as ChatGPT or Claude. However, Appleās version distinguishes itself by grounding its responses in peerāreviewed clinical sources, including The New England Journal of Medicine, the Journal of the American Medical Association, and Nature. The company says the answers are simplified for everyday understanding, and users can rate the responses and provide qualitative feedback.
In addition to textual interaction, participants may choose to share data from Appleās HealthKit platformāsuch as resting heart rate, activity levels, sleep patterns, or laboratory resultsāto receive more personalized suggestions. The app is also designed to help users prepare for medical appointments and, when necessary, direct them toward specific healthcare providers for concerns that require professional attention.
Data handling and privacy
According to TechCrunch, Apple has emphasized that all health data submitted through the study will be anonymized before being transmitted to a secure thirdāparty cloud environment. The company further states that the data will not be used to train any artificialāintelligence models. OpenEvidence, the partner firm, is reported to delete query and response data after a 24āhour retention period.
Leadership perspective
The announcement includes a statement from SumbulāÆDesai, M.D., Appleās viceāpresident of Health and Fitness. As reported by TechCrunch, Dr.āÆDesai said:
> āAt Apple, we believe responsible innovation starts with scientific rigor and clinical grounding. Health is deeply personal, and conducting a dedicated research study is the most thoughtful way to understand how people engage with, comprehend, and evaluate health AI in everyday life.ā
She added that insights from the study will āhelp advance the broader scientific conversation and ensure that as technology evolves, we continue building trusted tools that genuinely support people wherever they are on their health journey.ā
Context within the AIāhealth landscape
According to TechCrunch, Appleās move arrives as other AI labs such as OpenAI and Anthropic have introduced chatbots with healthāfocused capabilities. The article notes that OpenAI reported earlier in the year that users were submitting more than 300āÆmillion healthārelated queries each week, underscoring the growing demand for AIādriven medical information.
Potential future integration
The report states that Apple has not yet confirmed whether the AIāpowered answering functionality will be integrated into its existing Health app or Siri voice assistant. The company appears to be using the study as a researchāfirst approach before any broader product rollout.
--- Brief analysis (opinion): Appleās decision to conduct a largeāscale, clinically anchored study before launching a consumerāfacing AI health product reflects a cautious strategy aimed at addressing regulatory scrutiny and user trust concerns. By limiting data use to research and prohibiting model training, Apple differentiates its approach from competitors that leverage user interactions to improve their models. The partnership with OpenEvidence and the emphasis on peerāreviewed sources may position Apple as a more reliable source of health information, though the ultimate success will depend on user adoption, the quality of AI responses, and how the findings translate into product features.
--- Conclusion Appleās new study app represents a structured attempt to understand how everyday users interact with AIāgenerated health information when that information is anchored in established medical literature. By collecting feedback from a sizable participant pool while maintaining strict privacy safeguards, Apple aims to inform future healthātechnology offerings that balance innovation with clinical responsibility.
Source: TechCrunch
Frequently Asked Questions
Who is eligible to join Appleās AI health study?
According to TechCrunch, U.S. residents aged 21āÆor older who own an iPhoneāÆ15 or later, run iOSāÆ26 or later, and have Apple Intelligence enabled can enroll.
What sources does the app use to generate health answers?
As reported by TechCrunch, the appās responses are grounded in clinical data from *The New England Journal of Medicine*, the *Journal of the American Medical Association*, and *Nature*.
Will the data collected in the study be used to train Appleās AI models?
According to TechCrunch, the anonymized data will not be used for AI model training, and OpenEvidence deletes query and response data after 24āÆhours.